Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Smad1 , Smad8 (AA 456-465), (pSer463), (pSer465) anticorps

Cité dans 5 publications. Cet anticorps anti-Smad1 , Smad8 Monoclonal Rat (Clone N6-1233) (ABIN1177176) détecte spécifiquement Smad1 , Smad8 dans ICS, IHC et WB. L’anticorps est réactif avec des échantillons de Humain et Souris.
N° du produit ABIN1177176
305,85 €
Plus frais de livraison 40,00 € et TVA
0.1 mg
Destination: France
Envoi sous 12 à 15 jours ouvrables

Aperçu rapide pour Smad1 , Smad8 (AA 456-465), (pSer463), (pSer465) anticorps (ABIN1177176)

Antigène

Smad1 , Smad8

Reactivité

Humain, Souris

Hôte

  • 1
Rat

Clonalité

  • 1
Monoclonal

Conjugué

  • 1
Inconjugué

Application

Intracellular Staining (ICS), Immunohistochemistry (IHC), Western Blotting (WB)

Clone

N6-1233
  • Épitope

    AA 456-465, pSer463, pSer465

    Purification

    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

    Immunogène

    Phosphorylated Human Smad1 aa 456-465 Peptide

    Isotype

    IgG2a kappa
  • Protocole

    In human PBMC, overnight serum starvation was found to be necessary for detection of a BMP-6-induced increase in Smad1/8 phosphorylation. Serum starvation for 1 hour following PBMC isolation was not sufficient to reduce basal levels of Smad1 (pS463/pS465)/Smad8(pS465/pS467). Some donor variation was observed in the reduction of basal phosphorylation by overnight serum starvation.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    Aqueous buffered solution containing ≤0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Store undiluted at 4°C.
  • Whitman: "Smads and early developmental signaling by the TGFbeta superfamily." dans: Genes & development, Vol. 12, Issue 16, pp. 2445-62, (1998) (PubMed).

    Kretzschmar, Doody, Massagué: "Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1." dans: Nature, Vol. 389, Issue 6651, pp. 618-22, (1997) (PubMed).

    Kretzschmar, Liu, Hata, Doody, Massagué: "The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase." dans: Genes & development, Vol. 11, Issue 8, pp. 984-95, (1997) (PubMed).

    Hogan: "Bone morphogenetic proteins: multifunctional regulators of vertebrate development." dans: Genes & development, Vol. 10, Issue 13, pp. 1580-94, (1996) (PubMed).

    Hoodless, Haerry, Abdollah, Stapleton, OConnor, Attisano, Wrana: "MADR1, a MAD-related protein that functions in BMP2 signaling pathways." dans: Cell, Vol. 85, Issue 4, pp. 489-500, (1996) (PubMed).

  • Antigène

    Smad1 , Smad8

    Sujet

    The N6-1233 monoclonal antibody specifically binds to the Smad1 protein phosphorylated at the Ser463/465 sites and the Smad8 protein phosphorylated at the Ser465/467 sites. Smad1 and Smad8 are ~60 kDa proteins and are members of the Smad superfamily. The Smad family members are divided into three subfamilies: receptor regulated Smads or R-Smads, including Smads1, 2, 3, 5, and 8, common partner Smad, or Co-Smad, including Smad4, and inhibitory Smads, or I-Smad, including Smads 6 and 7. Activation of Transforming Growth Factor-beta (TGF-beta) superfamily serine/threonine kinase receptors, such as TGF-beta and Bone Morphogenic Protein (BMP) receptors, leads to the phosphorylation of R-Smads at several sites. It has been shown that Ser463 and Ser465 of Smad1 are phosphorylated by BMP receptors. In B cells and pre-B cells, BMP-6 has been shown to induce Smad1/5/8 phosphorylation and inhibit cell proliferation. Phosphorylated R-Smads form complexes with Co-Smad and translocate into the nucleus to regulate transcription affecting a wide range of critical processes including cell-fate determination, proliferation, morphogenesis, differentiation and apoptosis. The inhibitory Smads inhibit this pathway through two potential mechanisms: either by preventing R-Smads from binding to their corresponding receptors and/or by competing with Smad4, the Co-Smad, from binding to R-Smads. This antibody may crossreact with Smad5 pS463/pS465 based on sequence homology.
    Synonyms: Smad1,Smad8/Smad9, MADH1, MADH9

    Poids moléculaire

    ~ 60 kDa
Vous êtes ici:
Chat with us!